KHAIRY H MORSY; AMR ZAGHLOUL; MAGDY MAHMOUD. Can eicosapentaenoic acid maintain the original ribavirin dose or affect the response during the treatment course of chronic hepatitis C virus (HCV) patients?. Turkish Journal of Gastroenterology, [S. l.], v. 27, n. 1, p. 55–61, 2019. Disponível em: https://tjg.avesjournals.com/index.php/tjg/article/view/3219. Acesso em: 16 jul. 2025.